118 related articles for article (PubMed ID: 34153775)
21. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.
Perry JA; Kiezun A; Tonzi P; Van Allen EM; Carter SL; Baca SC; Cowley GS; Bhatt AS; Rheinbay E; Pedamallu CS; Helman E; Taylor-Weiner A; McKenna A; DeLuca DS; Lawrence MS; Ambrogio L; Sougnez C; Sivachenko A; Walensky LD; Wagle N; Mora J; de Torres C; Lavarino C; Dos Santos Aguiar S; Yunes JA; Brandalise SR; Mercado-Celis GE; Melendez-Zajgla J; Cárdenas-Cardós R; Velasco-Hidalgo L; Roberts CW; Garraway LA; Rodriguez-Galindo C; Gabriel SB; Lander ES; Golub TR; Orkin SH; Getz G; Janeway KA
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):E5564-73. PubMed ID: 25512523
[TBL] [Abstract][Full Text] [Related]
22. The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma.
Liu W; Cheng H; Huang Z; Li Y; Zhang Y; Yang Y; Jin T; Sun Y; Deng Z; Zhang Q; Lou F; Cao S; Wang H; Niu X
Mol Oncol; 2024 Apr; 18(4):939-955. PubMed ID: 37727135
[TBL] [Abstract][Full Text] [Related]
23. ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway.
Li H; Shen X; Ma M; Liu W; Yang W; Wang P; Cai Z; Mi R; Lu Y; Zhuang J; Jiang Y; Song Y; Wu Y; Shen H
J Exp Clin Cancer Res; 2021 Oct; 40(1):340. PubMed ID: 34706747
[TBL] [Abstract][Full Text] [Related]
24. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma.
Smida J; Xu H; Zhang Y; Baumhoer D; Ribi S; Kovac M; von Luettichau I; Bielack S; O'Leary VB; Leib-Mösch C; Frishman D; Nathrath M
Int J Cancer; 2017 Aug; 141(4):816-828. PubMed ID: 28494505
[TBL] [Abstract][Full Text] [Related]
26. Molecular profiling of osteosarcoma in children and adolescents from different age groups using a next-generation sequencing panel.
Guimarães GM; Tesser-Gamba F; Petrilli AS; Donato-Macedo CRP; Alves MTS; de Lima FT; Garcia-Filho RJ; Oliveira R; Toledo SRC
Cancer Genet; 2021 Nov; 258-259():85-92. PubMed ID: 34666222
[TBL] [Abstract][Full Text] [Related]
27. Individualized combination therapies based on whole-exome sequencing displayed significant clinical benefits in a glioblastoma patient with secondary osteosarcoma: case report and genetic characterization.
Yi GZ; Zhu TC; Que TS; Li ZY; Huang GL
BMC Neurol; 2022 Oct; 22(1):390. PubMed ID: 36271359
[TBL] [Abstract][Full Text] [Related]
28. Prognostic potential of whole exome sequencing in the clinical management of metachronous colorectal cancer liver metastases.
Heczko L; Hlaváč V; Holý P; Dvořák P; Liška V; Vyčítal O; Fiala O; Souček P
Cancer Cell Int; 2023 Nov; 23(1):295. PubMed ID: 38008721
[TBL] [Abstract][Full Text] [Related]
29. The insertion and dysregulation of transposable elements in osteosarcoma and their association with patient event-free survival.
Wang C; Liang C
Sci Rep; 2022 Jan; 12(1):377. PubMed ID: 35013466
[TBL] [Abstract][Full Text] [Related]
30. Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers.
Cho SY; Chae J; Na D; Kang W; Lee A; Min S; Kang J; Choi B; Lee J; Sung CO; Chuang JH; Lee C; Lee WS; Park H; Kim JI
Clin Cancer Res; 2019 May; 25(9):2821-2834. PubMed ID: 30670495
[TBL] [Abstract][Full Text] [Related]
31. A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer.
Kaur P; Campo D; Porras TB; Ring A; Lu J; Chairez Y; Su Y; Kang I; Lang JE
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650480
[TBL] [Abstract][Full Text] [Related]
32. Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.
Di J; Yang H; Jiang B; Wang Z; Ji J; Su X
Int J Cancer; 2018 Mar; 142(5):927-939. PubMed ID: 29105743
[TBL] [Abstract][Full Text] [Related]
33. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
34.
Sakthikumar S; Elvers I; Kim J; Arendt ML; Thomas R; Turner-Maier J; Swofford R; Johnson J; Schumacher SE; Alföldi J; Axelsson E; Couto CG; Kisseberth WC; Pettersson ME; Getz G; Meadows JRS; Modiano JF; Breen M; Kierczak M; Forsberg-Nilsson K; Marinescu VD; Lindblad-Toh K
Cancer Res; 2018 Jul; 78(13):3421-3431. PubMed ID: 29724721
[TBL] [Abstract][Full Text] [Related]
35. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
Chen X; Bahrami A; Pappo A; Easton J; Dalton J; Hedlund E; Ellison D; Shurtleff S; Wu G; Wei L; Parker M; Rusch M; Nagahawatte P; Wu J; Mao S; Boggs K; Mulder H; Yergeau D; Lu C; Ding L; Edmonson M; Qu C; Wang J; Li Y; Navid F; Daw NC; Mardis ER; Wilson RK; Downing JR; Zhang J; Dyer MA;
Cell Rep; 2014 Apr; 7(1):104-12. PubMed ID: 24703847
[TBL] [Abstract][Full Text] [Related]
36. Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy.
Kuijjer ML; van den Akker BE; Hilhorst R; Mommersteeg M; Buddingh EP; Serra M; Bürger H; Hogendoorn PC; Cleton-Jansen AM
BMC Med Genomics; 2014 Jan; 7():4. PubMed ID: 24447333
[TBL] [Abstract][Full Text] [Related]
37. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
[TBL] [Abstract][Full Text] [Related]
38. The genetic basis for inactivation of Wnt pathway in human osteosarcoma.
Du X; Yang J; Yang D; Tian W; Zhu Z
BMC Cancer; 2014 Jun; 14():450. PubMed ID: 24942472
[TBL] [Abstract][Full Text] [Related]
39. Tiered analysis of whole-exome sequencing for epilepsy diagnosis.
Dunn PJ; Maher BH; Albury CL; Stuart S; Sutherland HG; Maksemous N; Benton MC; Smith RA; Haupt LM; Griffiths LR
Mol Genet Genomics; 2020 May; 295(3):751-763. PubMed ID: 32146541
[TBL] [Abstract][Full Text] [Related]
40. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
